Medication Management

The Doctor’s Lawyer: A suspension means no work
A college suspension means not only can’t you see patients, you can’t do admin or other work in the clinic—except to finalize outstanding reports.
Perspective on the new National Pharmacare framework
Universal coverage can be achieved without implementing a single payor system that could potentially introduce other unintended consequences, says the CEO of the Ontario Pharmacists Association.

Drug rep details

Interactions and expectations between physicians and pharma reps are changing.
Why the time is right to participate in EMR-based primary care research

‘You can’t improve what you don’t measure.’
‘Not consulted’: Alberta health minister questions Ottawa’s national pharmacare plan

The plan as it stands would allow every Canadian with a health card to access free diabetes medication and birth control.
Proposed ODB changes counterbalanced by cancelled reconciliation mechanism

Ontario pharmacies will be $39 million better off after both changes.
Alarming growth in ‘patient steering’: CPhA calls on Canada to regulate PPN arrangements

The Canadian Pharmacists Association says its firmly against payer-directed care and wants several regulatory changes to protect Canadian patients.
On addressing the shortage of family doctors now

A retired FP looks at the disparity between the fees paid to him decades ago and what the inflation-adjusted amounts should be—and what Ontario actually pays now.
Freeland pledges pharmacare deal won’t jeopardize federal finances

The NDP confirmed on Friday that it reached a deal on pharmacare with the Liberals, which would allow every Canadian with a health card to access free diabetes medication and birth control.
Optimizing medications and reducing polypharmacy through medication reviews

The European iSIMPATHY project proves the value of a seven steps approach to medication reviews, enabling pharmacists to manage polypharmacy.

The Doctor’s Lawyer: A suspension means no work

Perspective on the new National Pharmacare framework

Drug rep details

Why the time is right to participate in EMR-based primary care research

‘Not consulted’: Alberta health minister questions Ottawa’s national pharmacare plan

Proposed ODB changes counterbalanced by cancelled reconciliation mechanism

Alarming growth in ‘patient steering’: CPhA calls on Canada to regulate PPN arrangements

On addressing the shortage of family doctors now

Freeland pledges pharmacare deal won’t jeopardize federal finances

Optimizing medications and reducing polypharmacy through medication reviews